Insider Selling: Shoulder Innovations (NYSE:SI) Major Shareholder Sells 3,900 Shares

Key Points

• Major shareholder Healthcare Holding B.V. Gilde sold 3,900 Shoulder Innovations shares at an average price of $22.60, generating $88,140. The sale reduced its position by 0.18%, leaving it with 2.21 million shares valued at approximately $49.9 million.
• Gilde has conducted several additional sales since late July, including the sale of 99,812 shares on August 4 and 20,516 shares on August 21, indicating a broader pattern of insider selling.
• Shoulder Innovations shares recently traded at $22.24, near their 12-month high of $24.59. Analysts maintain a “Moderate Buy” consensus, with an average price target of $23.50, despite the company missing its latest quarterly EPS estimate and reporting a net loss.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 3,900 shares of the business's stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $22.60, for a total value of $88,140.00. Following the transaction, the insider owned 2,208,307 shares in the company, valued at $49,907,738.20. The trade was a 0.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total value of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total transaction of $463,866.76.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Performance

SI traded up $0.18 during trading hours on Monday, hitting $22.24. 75,051 shares of the stock were exchanged, compared to its average volume of 128,345. The stock has a market cap of $463.02 million and a price-to-earnings ratio of -11.58. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. The stock has a 50-day simple moving average of $21.03 and a 200-day simple moving average of $16.60.

Shoulder Innovations (NYSE:SI - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. Analysts anticipate that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Institutional Trading of Shoulder Innovations

Several hedge funds have recently modified their holdings of SI. California State Teachers Retirement System increased its position in Shoulder Innovations by 412.4% in the second quarter. California State Teachers Retirement System now owns 2,941 shares of the company's stock worth $60,000 after purchasing an additional 2,367 shares during the period. Compass Financial Management LLC acquired a new stake in shares of Shoulder Innovations in the 2nd quarter valued at approximately $30,000. Bank of America Corp DE boosted its stake in Shoulder Innovations by 43.7% during the 1st quarter. Bank of America Corp DE now owns 26,983 shares of the company's stock worth $392,000 after acquiring an additional 8,205 shares during the last quarter. Royal Bank of Canada grew its holdings in Shoulder Innovations by 7,046.3% during the first quarter. Royal Bank of Canada now owns 53,883 shares of the company's stock valued at $783,000 after purchasing an additional 53,129 shares during the period. Finally, KCM Capital Inc bought a new stake in Shoulder Innovations in the first quarter valued at approximately $509,000.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SI. BTIG Research boosted their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, August 7th. UBS Group increased their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Monday, August 10th. Piper Sandler restated an "overweight" rating and issued a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Finally, Weiss Ratings raised Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a research report on Monday, August 3rd. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $23.50.

Shoulder Innovations Company Profile

Shoulder Innovations NYSE: SI is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source